Bellerophon Therapeutics competitorsClear all

Bellerophon Therapeutics's top competitors include Innovation Pharmaceuticals, Urovant Sciences, Cellestia Biotech and Deciphera Pharmaceuticals.
Bellerophon Therapeutics
Bellerophon Therapeutics
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
Innovation Pharmaceuticals
Innovation Pharmaceuticals
Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.
Urovant Sciences
Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
Cellestia Biotech
Cellestia Biotech
Cellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company.
Founding Date
Founding Date
2009
Founding Date
2007
Founding Date
2016
Founding Date
2014
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Warren, US HQ
Locations
Wakefield, US HQ
Beverly, US
Locations
Irvine, US HQ
Basel, CH
Locations
Basel, CH HQ
Epalinges, CH
Locations
Waltham, US HQ
Lawrence, US
Waltham, US
Employees
Employees
1715% decrease
Employees
450% decrease
Employees
3950% increase
Employees
6
Employees
438% increase
Valuation ($)
Valuation ($)
75.1 m
Valuation ($)
90.1 m
Valuation ($)
513.6 m
Valuation ($)
N/A
Valuation ($)
2.7 b
Twitter followers
Twitter followers
N/A
Twitter followers
182
Twitter followers
109
Twitter followers
143
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
264284
Alexa Website Rank
226808
Alexa Website Rank
450870
Alexa Website Rank
374283
Alexa Website Rank
288837
Employee Rating
Employee Rating
1
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.6

Financial

Net income
Net income
($13.3m) (FY, 2019)
Net income
($6.6m) (FY, 2020)
Net income
($146.7m) (FY, 2020)
Net income
N/A
Net income
($25.9m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 80m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 48.6m
Total funding raised
$ 142m
For sources of this data, please see the company profile

View company profiles

Innovation Pharmaceuticals
HQ
Wakefield, US
Employees
4↓ 50% decrease

Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.

View company
Urovant Sciences
HQ
Irvine, US
Employees
39↑ 50% increase

Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.

View company
Cellestia Biotech
HQ
Basel, CH
Employees
6

Cellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.

View company
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
43↑ 8% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company.

View company